Volume 89, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



To date, existing studies focus largely on the economic detriments of malaria. However, if we are to create suitable incentives for larger-scale, more sustained anti-malaria efforts from a wider group of stakeholders, we need a much better understanding of the economic benefits of malaria reduction and elimination. Our report seeks to rectify this disjuncture by showing how attaining the funding needed to meet internationally agreed targets for malaria elimination would, on conservative assumptions, generate enormous economic improvements. We use a cost-benefit analysis anchored in Global Malaria Action Plan projections of malaria eradication based on fully met funding goals. By calculating the value of economic output accrued caused by work years saved and subtracting the costs of intervention, we find that malaria reduction and elimination during 2013–2035 has a 2013 net present value of US $208.6 billion.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Article metrics loading...

Loading full text...

Full text loading...



  1. World Health Organization, 2012. Malaria Fact Sheet. Available at: http://www.who.int/mediacentre/factsheets/fs094/en/. Accessed January 10, 2013.
  2. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD, , 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413431.[Crossref]
  3. Attaran A, Narasimhan V, , 2003. Roll back malaria? The scarcity of international aid for malaria control. Malar J 2: 8.[Crossref]
  4. McCarthy FD, Wolf H, Wu Y, , 2000. The Growth Costs of Malaria. National Bureau of Economic Research working paper 7541. Available at: http://www.nber.org/papers/w7541.pdf. Accessed April 14, 2013.
  5. Sachs J, Malaney P, , 2002. The economic and social burden of malaria. Nature 415: 680685.[Crossref]
  6. Gallup JL, Sachs JD, , 2001. The economic burden of malaria. Am J Trop Med Hyg 64: 8596.
  7. Lucas AM, , 2010. Malaria eradication and educational attainment: evidence from Paraguay and Sri Lanka. Am Economic J–Applied Economics 2: 4671.[Crossref]
  8. Shepard DS, Ettling MB, Brinkmann U, Sauerborn R, , 1991. The economic cost of malaria in Africa. Trop Med Parasitol 423: 199203.
  9. Breman J, Mills A, Snow RW, Mulligan J-A, Lengeler C, Mendis K, Sharp B, Morel C, Marchesini P, White NJ, Steketee RW, Doumbo OK, , 2006. Conquering Malaria. Disease Control Priorities in Developing Countries. Second edition. New York: Oxford University Press.
  10. White MT, Conteh L, Cibulskis R, Ghani AC, , 2011. Costs and cost-effectiveness of malaria control interventions–a systematic review. Malar J 10: 337.[Crossref]
  11. Sabot O, Moonen B, Yamey G, Jones A, Cohen J, Santos A, Ward A, Reidy M, Higbie M, , 2011. Maintaining the Gains in Global Malaria Control. Clinton Health Access Initiative. Available at: http://globalhealthsciences.ucsf.edu/sites/default/files/content/ghg/e2pi-maintaining-the-gains.pdf. Accessed May 10, 2013.
  12. Erskine M, Lynch M, , 2011. Quantification for Universal Coverage. African Leaders Malaria Alliance. Available at: http://www.alma2015.org/sites/default/files/docs/alma_unicef_quant_021411.pdf. Accessed May 10, 2013.
  13. Clinton Health Access Initiative, 2011. Maintaining the Gains in Global Malaria Control. Available at: http://globalhealthsciences.ucsf.edu/sites/default/files/content/ghg/e2pi-maintaining-the-gains-country-briefs.pdf. Accessed May 10, 2013.
  14. Ajayi IO, Browne EM, Garshong B, Bateganya F, Yusuf B, Agyei-Baffour P, Doamekpor L, Balyeku A, Munguti K, Cousens S, Pagnoni F, , 2008. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J 7: 6.[Crossref]
  15. Cibulskis R, , 2008. WHO Informal Consultation on Global Malaria Control and Elimination: A Technical Review. Geneva: World Health Organization.
  16. Nayyar GML, Breman JG, Newton PN, Herrington J, , 2012. Poor-quality antimalarial drugs in Southeast Asia and sub-Saharan Africa. Lancet Infect Dis 12: 488496.[Crossref]
  17. Hanson K, Goodman C, Lines J, Meek S, Bradley D, Mills A, , 2004. The Economics of Malaria Control Interventions. The Global Forum for Health Research, January 2004. Available at: http://whqlibdoc.who.int/publications/2004/2940286159.pdf. Accessed May 10, 2013.
  18. Laxminarayan R, , 2004. Act now or later? Economics of malaria resistance. Am J Trop Med Hyg 71: 187195.
  19. Goodman C, Coleman P, Mills A, , 2009. Economic Analysis of Malaria Control in Sub-Saharan Africa. The Global Forum for Health Research, May 2000. Available at: http://www.givewell.org/files/DWDA%202009/Analysis/Economic%20Analysis%20of%20Malaria%20Control%20in%20Sub-Saharan%20Africa.pdf. Accessed May 10, 2013.
  20. United Kingdom Department for International Development, 2010. Malaria: Burden and Interventions. Available at: http://www.dfid.gov.uk/Documents/prd/malaria-evidence-paper.pdf. Accessed May 14, 2013.
  21. United Republic of Tanzania Ministry of Finance, 2011. Government Budget for Financial year 2011–2012. Calculation Based on the Total Education Budget of Financial Year 2010–2011. Available at: http://nexus.som.yale.edu/ph-tanzania/sites/nexus.som.yale.edu.ph-tanzania/files/imce_imagepool/Tz_Budget_2011_2012.pdf. Accessed May 14, 2013.
  22. World Economic Forum, 2006. Business and Malaria: A Neglected Threat? Available at: https://members.weforum.org/pdf/MalariaReport.pdf. Accessed October 1, 2012.
  23. World Health Organization, 2011. World Malaria Report 2011. Geneva: World Health Organization. Available at: http://www.who.int/malaria/world_malaria_report_2011/9789241564403_eng.pdf. Accessed September 6, 2012.

Data & Media loading...

  • Received : 15 Nov 2012
  • Accepted : 30 Jun 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error